Miklós Poór

Dr. Miklós Poór

University of Pecs, Pécs, Baranya, Hungary
orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 April 2016 in Toxins
Verified
Journal Article
Open access
PDF file
TKTamás Kőszegi
Tamás Kőszegi
Miklós PoórMiklós Poór
Miklós Poór
Ochratoxin A (OTA) is a widely-spread mycotoxin all over the world causing major health risks. The focus of the present review is on the molecular and cellular interactions of OTA. In order to get better insight into the mechanism of its toxicity and on the several attempts made for prevention or attenuation of its toxic action, a detailed description is given on chemistry and toxicokinetics of this mycotoxin. The mode of action of OTA is not clearly understood yet, and seems to be very complex. Inhibition of protein synthesis and energy production, induction of oxidative stress, DNA adduct formation, as well as apoptosis/necrosis and cell cycle arrest are possibly involved in its toxic action. Since OTA binds very strongly to human and animal albumin, a major emphasis is done regarding OTA-albumin interaction. Displacement of OTA from albumin by drugs and by natural flavonoids are discussed in detail, hypothesizing their potentially beneficial effect in order to prevent or attenuate the OTA-induced toxic consequences.

31 July 2020 in Nutrients
Verified
Journal Article
Open access
PDF file
VMVioletta Mohos
Violetta Mohos
EFEszter Fliszár-Nyúl
Eszter Fliszár-Nyúl
OUOrsolya Ungvári
Orsolya Ungvári
KKKatalin Kuffa
Katalin Kuffa
PNPaul Needs
Paul Needs
Miklós PoórMiklós Poór
Miklós Poór
Quercetin is a flavonoid, its glycosides and aglycone are found in significant amounts in several plants and dietary supplements. Because of the high presystemic biotransformation of quercetin, mainly its conjugates appear in circulation. As has been reported in previous studies, quercetin can interact with several proteins of pharmacokinetic importance. However, the interactions of its metabolites with biotransformation enzymes and drug transporters have barely been examined. In this study, the inhibitory effects of quercetin and its most relevant methyl, sulfate, and glucuronide metabolites were tested on cytochrome P450 (CYP) (2C19, 3A4, and 2D6) enzymes as well as on organic anion-transporting polypeptides (OATPs) (OATP1A2, OATP1B1, OATP1B3, and OATP2B1) and ATP (adenosine triphosphate) Binding Cassette (ABC) (BCRP and MRP2) transporters. Quercetin and its metabolites (quercetin-3′-sulfate, quercetin-3-glucuronide, isorhamnetin, and isorhamnetin-3-glucuronide) showed weak inhibitory effects on CYP2C19 and 3A4, while they did not affect CYP2D6 activity. Some of the flavonoids caused weak inhibition of OATP1A2 and MRP2. However, most of the compounds tested proved to be strong inhibitors of OATP1B1, OATP1B3, OATP2B1, and BCRP. Our data demonstrate that not only quercetin but some of its conjugates, can also interact with CYP enzymes and drug transporters. Therefore, high intake of quercetin may interfere with the pharmacokinetics of drugs.

1 May 2017 in Journal of Photochemistry and Photobiology B: Biology
Verified
Journal Article
Closed access
Miklós PoórMiklós Poór
Miklós Poór
SKSándor Kunsági-Máté
Sándor Kunsági-Máté
MBMónika Bálint
Mónika Bálint
CHCsaba Hetényi
Csaba Hetényi
ZGZsófia Gerner
Zsófia Gerner
BLBeáta Lemli
Beáta Lemli

1 January 2014 in Journal of Luminescence
Verified
Journal Article
Closed access
Miklós PoórMiklós Poór
Miklós Poór
YLYin Li
Yin Li
GMGergely Matisz
Gergely Matisz
LKLászló Kiss
László Kiss
SKSándor Kunsági-Máté
Sándor Kunsági-Máté
TKTamás Kőszegi
Tamás Kőszegi

1 April 2017 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Closed access
Miklós PoórMiklós Poór
Miklós Poór
GBGabriella Boda
Gabriella Boda
PNPaul W. Needs
Paul W. Needs
PKPaul Kroon
Paul Kroon
BLBeáta Lemli
Beáta Lemli
TBTímea Bencsik
Tímea Bencsik

1 October 2020 in Drug Metabolism and Disposition
Verified
Journal Article
Closed access
PDF file
VMVioletta Mohos
Violetta Mohos
EFEszter Fliszár-Nyúl
Eszter Fliszár-Nyúl
OUOrsolya Ungvári
Orsolya Ungvári
ÉBÉva Bakos
Éva Bakos
KKKatalin Kuffa
Katalin Kuffa
Miklós PoórMiklós Poór
Miklós Poór
Chrysin is an abundant flavonoid in nature, and it is also contained by several dietary supplements. Chrysin is highly biotransformed in the body, during which conjugated metabolites, chrysin-7-sulfate and chrysin-7-glucuronide are formed. These conjugates appear at considerably higher concentrations in the circulation than the parent compound. Based on previous studies, chrysin can interact with biotransformation enzymes and transporters; however, the interactions of its metabolites have been barely examined. In this in vitro study, the effects of chrysin, chrysin-7-sulfate, and chrysin-7-glucuronide on CYP (2C9, 2C19, 3A4, and 2D6) as well as on Organic anion-transporting polypeptides (OATPs, 1A2, 1B1, 1B3, and 2B1) and ATP Binding Cassette (ABC: P-gp, MRP2, and BCRP) transporters were investigated. Our observations revealed that chrysin conjugates are strong inhibitors of certain biotransformation enzymes (e.g., CYP2C9) and transporters (e.g., OATP1B1, OATP1B3, OATP2B1, and BCRP) examined. Therefore, the simultaneous administration of chrysin-containing dietary supplements with medications needs to be carefully considered due to the possible development of pharmacokinetic interactions. Significance Statement Chrysin-7-sulfate and chrysin-7-glucuronide are the major metabolites of flavonoid chrysin. In this study, we examined the effects of chrysin and its conjugates on cytochrome P450 enzymes, and on Organic anion-transporting polypeptides and ATP Binding Cassette transporters (P-gp, BCRP, and MRP2). Our results demonstrate that chrysin and/or its conjugates can significantly inhibit some of these proteins. Since chrysin is also contained by dietary supplements, high intake of chrysin may interrupt the transport and/or the biotransformation of drugs.